Metformin Stada

Metformin Hydrochloride, the active ingredient in Metformin Stada, is a biguanide presented as an oral tablet for oral use. It improves glycemic control in adults with type 2 diabetes mellitus by decreasing hepatic glucose output and enhancing peripheral insulin sensitivity.

GNH USA supplies Metformin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides full regulatory documentation to support global distribution.

Metformin Stada is a biguanide indicated for disorders of glucose metabolism, primarily type 2 diabetes mellitus. - Type 2 diabetes mellitus: improves glycemic control when used with diet and exercise. - Insulin resistance: enhances peripheral insulin sensitivity to lower blood glucose levels. - Hyperglycemia: reduces hepatic glucose production, decreasing fasting plasma glucose concentrations.

Metformin Stada may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or pain. - Metallic taste: transient alteration of taste perception. - Loss of appetite: reduced desire to eat. - Flatulence: increased intestinal gas.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic disturbance. - Severe hypoglycemia: especially when combined with insulin or sulfonylureas. - Vitamin B12 deficiency: may develop with long‑term therapy. - Hepatic dysfunction: rare liver enzyme elevations. - Skin rash: occasional allergic skin reactions. - Pancreatitis: very rare inflammation of the pancreas.

Metformin Stada requires careful patient assessment and monitoring to minimise risks. - Renal function: assess eGFR before initiating and periodically thereafter. - Lactic acidosis risk: avoid in patients with severe renal or hepatic impairment. - Alcohol consumption: limit intake to reduce lactic acidosis potential. - Pregnancy: use only if potential benefit justifies the risk to the fetus. - Monitoring: check vitamin B12 levels periodically during long‑term therapy. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Metformin Stada can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate acute renal failure. - Cimetidine: can increase metformin plasma concentrations. - Alcohol: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors or ARBs: monitor renal function and electrolytes.